<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 69-year-old male patient with <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>) was found to have a consistent chromosomal abnormality, t(6;9)(p22.3;q34), in the bone marrow and unstimulated peripheral blood cells </plain></SENT>
<SENT sid="1" pm="."><plain>Twenty patients with t(6;9) and <z:hpo ids='HP_0001909'>leukemia</z:hpo> have been reported; some of them had a <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) before developing overt ANLL </plain></SENT>
<SENT sid="2" pm="."><plain>Our patient was still in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> stage when the t(6;9) was found </plain></SENT>
<SENT sid="3" pm="."><plain>This result suggests that t(6;9) represents one of the pathways from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> to <z:hpo ids='HP_0001909'>leukemia</z:hpo> in patients with ANLL </plain></SENT>
</text></document>